Karyopharm Therapeutics Overview

Karyopharm Therapeutics Total Revenue

Revenue analysis for KPTI.

Quarterly Revenue

$35.07M

↑ 16.83% YoY

As of Mar 2026

Annual Revenue (TTM)

$151.12M

↑ 13.74% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin